Meet with NETRIS Pharma at the ESMO Congress in Paris (September 9-13, 2022)

Reading : 1 min

NETRIS Pharma, a clinical-stage immuno-oncology pharmaceutical company pioneering dependence receptors-based drug discovery and development, is confirming that :

  • CEO and Founder Patrick Mehlen,
  • CMO Frédéric Le Bras, and
  • CFO Christophe Guichard,

will be attending the ESMO Congress taking place September 9-13, 2022, in Paris. Come and meet with us !

For any information, please send an email to  christopheguichard@netrispharma.com

All details at : https://www.esmo.org/meetings/esmo-congress-2022